Publisher's Synopsis
Collagen biomaterials have gained significant attention in the development of wound treatments due to their similarity to the extracellular matrix (ECM) in the human body. Bovine tissue has emerged as an unexplored source of collagen biomaterials, and studies have shown promising results in their effectiveness for wound healing. This article by S. Udhayakumar focuses on the development of collagen biomaterials from bovine tissue for wound treatment and their in vitro, in vivo, and clinical validation. The extracellular matrix is a complex network of proteins and other molecules that provide structural and biochemical support to cells. Collagen, the most abundant protein in the ECM, is responsible for providing tensile strength and structural support. In wound healing, the ECM plays a crucial role in regulating cell behavior and signaling, and collagen biomaterials mimic the natural ECM, making them ideal for wound treatment. The development of collagen biomaterials involves the extraction of collagen from bovine tissue and processing it into various forms, such as scaffolds, hydrogels, matrices, fibers, peptides, and fibrils. These biomaterials can be used for wound closure devices, wound dressings, and wound closure systems. The biomaterials are designed to promote wound healing by facilitating angiogenesis, cell migration, and inflammation reduction while preventing scar formation. In vitro studies have shown that collagen biomaterials support the growth and function of fibroblasts and keratinocytes, two essential cell types in wound healing. These studies have also demonstrated that collagen biomaterials support wound closure time and promote wound bed preparation. In vivo studies in animal models have shown that collagen biomaterials promote wound closure, and they are safe and effective for use in wound healing. Clinical trials have also demonstrated the effectiveness of collagen biomaterials in treating chronic wounds, acute wounds, burn wounds, diabetic foot ulcers, pressure ulcers, and surgical wounds. Collagen biomaterials' success is due to their similarity to the human ECM, which makes them highly biocompatible and biodegradable, making them ideal for use in tissue engineering and regenerative medicine. Collagen biomaterials can also be used for environmental remediation, sustainable agriculture, and waste management. In conclusion, collagen biomaterials derived from bovine tissue have significant potential in wound treatment development. Their in vitro, in vivo, and clinical validation shows that they are highly effective for wound closure and safe for use. Collagen biomaterials are sustainable, eco-friendly, and highly adaptable for different wound types and wound management strategies.
